Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acemannan versus triamcinolone acetonide in orabase for aphthous ulceration
TCTR20171013001Phase 2Not yet recruiting
- Sponsor
- Faculty of Dentistry, Naresuan University
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acemannan, triamcinolone acetonide in aphthosis (RAS), sponsored by Faculty of Dentistry, Naresuan University. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
acemannantriamcinolone acetonide
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on TCTR20171013001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171013001.